LDL Receptor Regulates the Reverse Transport of Macrophage-Derived Unesterified Cholesterol via Concerted Action of the HDL-LDL Axis
暂无分享,去创建一个
D. Gómez-Coronado | M. Jauhiainen | J. Metso | Antonio Pérez | N. Rotllan | P. Kovanen | J. Girona | N. Plana | L. Masana | F. Blanco-Vaca | J. Julve | V. Llorente‐Cortés | J. Escolà-Gil | L. Cedó | D. Santos | A. García-León | Sònia Sabaté-Soler | Andrea Rivas-Urbina | K. A. Méndez-Lara | M. Tondo | V. Pallarès | Aleyda Benitez-Amaro | Anna-Kaisa Ruotsalainen | A. Levonen | J. L. Sánchez-Quesada | M. Lee-Rueckert | A. Rivas-Urbina
[1] Richard G. Lee,et al. Targeted Deletion of Hepatocyte Abca1 Increases Plasma HDL (High-Density Lipoprotein) Reverse Cholesterol Transport via the LDL (Low-Density Lipoprotein) Receptor. , 2019, Arteriosclerosis, thrombosis, and vascular biology.
[2] E. Fisher,et al. HDL and Reverse Cholesterol Transport. , 2019, Circulation research.
[3] A. Grefhorst,et al. The TICE Pathway: Mechanisms and Lipid-Lowering Therapies. , 2019, Methodist DeBakey cardiovascular journal.
[4] A. Tall. Plasma high density lipoproteins: Therapeutic targeting and links to atherogenic inflammation. , 2018, Atherosclerosis.
[5] M. Jauhiainen,et al. Altered HDL Remodeling and Functionality in Familial Hypercholesterolemia. , 2018, Journal of the American College of Cardiology.
[6] A. Gotto,et al. ABCA1-Derived Nascent High-Density Lipoprotein–Apolipoprotein AI and Lipids Metabolically Segregate , 2017, Arteriosclerosis, thrombosis, and vascular biology.
[7] B. van de Sluis,et al. News on the molecular regulation and function of hepatic low-density lipoprotein receptor and LDLR-related protein 1 , 2017, Current opinion in lipidology.
[8] Xiaoke Yin,et al. Very-Low-Density Lipoprotein–Associated Apolipoproteins Predict Cardiovascular Events and Are Lowered by Inhibition of APOC-III , 2017, Journal of the American College of Cardiology.
[9] Shailendra B. Patel,et al. Evidence that the adenosine triphosphate‐binding cassette G5/G8‐independent pathway plays a determinant role in cholesterol gallstone formation in mice , 2016, Hepatology.
[10] P. Kovanen,et al. HDL functionality in reverse cholesterol transport--Challenges in translating data emerging from mouse models to human disease. , 2016, Biochimica et biophysica acta.
[11] V. Fuster,et al. Induction of Sustained Hypercholesterolemia by Single Adeno-Associated Virus–Mediated Gene Transfer of Mutant hPCSK9 , 2015, Arteriosclerosis, thrombosis, and vascular biology.
[12] M. Phillips. Molecular Mechanisms of Cellular Cholesterol Efflux* , 2014, The Journal of Biological Chemistry.
[13] J. Heeren,et al. High density lipoprotein metabolism in low density lipoprotein receptor-deficient mice1[S] , 2014, Journal of Lipid Research.
[14] C. Ballantyne,et al. Modest diet-induced weight loss reduces macrophage cholesterol efflux to plasma of patients with metabolic syndrome. , 2013, Journal of clinical lipidology.
[15] K. Moore,et al. Macrophages in atherosclerosis: a dynamic balance , 2013, Nature Reviews Immunology.
[16] B. Pillot,et al. Transintestinal Cholesterol Excretion Is an Active Metabolic Process Modulated by PCSK9 and Statin Involving ABCB1 , 2013, Arteriosclerosis, thrombosis, and vascular biology.
[17] M. Phillips,et al. Serum albumin acts as a shuttle to enhance cholesterol efflux from cells[S] , 2013, Journal of Lipid Research.
[18] H. Low,et al. Mechanism of cholesterol efflux in humans after infusion of reconstituted high-density lipoprotein. , 2012, European heart journal.
[19] M. Jauhiainen,et al. The Cholesterol Content of Western Diets Plays a Major Role in the Paradoxical Increase in High-Density Lipoprotein Cholesterol and Upregulates the Macrophage Reverse Cholesterol Transport Pathway , 2011, Arteriosclerosis, thrombosis, and vascular biology.
[20] H. Kruth. Receptor-independent fluid-phase pinocytosis mechanisms for induction of foam cell formation with native low-density lipoprotein particles , 2011, Current opinion in lipidology.
[21] D. Rader,et al. Biliary sterol secretion is required for functional in vivo reverse cholesterol transport in mice. , 2011, Gastroenterology.
[22] A. Vaughan,et al. Effects of acceptor composition and mechanism of ABCG1-mediated cellular free cholesterol efflux* , 2009, Journal of Lipid Research.
[23] A. Guillaumet-Adkins,et al. CETP activity variation in mice does not affect two major HDL antiatherogenic properties: macrophage-specific reverse cholesterol transport and LDL antioxidant protection. , 2008, Atherosclerosis.
[24] D. Rader,et al. Expression of Cholesteryl Ester Transfer Protein in Mice Promotes Macrophage Reverse Cholesterol Transport , 2007, Circulation.
[25] H. Brewer,et al. ABCA1 Overexpression in the Liver of LDLr-KO Mice Leads to Accumulation of Pro-atherogenic Lipoproteins and Enhanced Atherosclerosis* , 2006, Journal of Biological Chemistry.
[26] Charles C Schwartz,et al. Lipoprotein cholesteryl ester production, transfer, and output in vivo in humans Published, JLR Papers in Press, May 16, 2004. DOI 10.1194/jlr.M300511-JLR200 , 2004, Journal of Lipid Research.
[27] A. Tall,et al. ATP-binding cassette transporters G1 and G4 mediate cellular cholesterol efflux to high-density lipoproteins. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[28] A. Rigotti,et al. The role of the high-density lipoprotein receptor SR-BI in the lipid metabolism of endocrine and other tissues. , 2003, Endocrine reviews.
[29] A. Cooper,et al. LDL receptor-related protein mediates cell-surface clustering and hepatic sequestration of chylomicron remnants in LDLR-deficient mice. , 2001, The Journal of clinical investigation.
[30] F. Grosveld,et al. Human plasma phospholipid transfer protein increases the antiatherogenic potential of high density lipoproteins in transgenic mice. , 2000, Arteriosclerosis, thrombosis, and vascular biology.
[31] M. Ala-Korpela,et al. Modified LDL – trigger of atherosclerosis and inflammation in the arterial intima , 2000, Journal of internal medicine.
[32] Robert V Farese,et al. Phenotypic analysis of mice expressing exclusively apolipoprotein B48 or apolipoprotein B100. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[33] L. Nielsen,et al. Transfer of low density lipoprotein into the arterial wall and risk of atherosclerosis. , 1996, Atherosclerosis.
[34] N. Maeda,et al. The two-receptor model of lipoprotein clearance: tests of the hypothesis in "knockout" mice lacking the low density lipoprotein receptor, apolipoprotein E, or both proteins. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[35] Robert V Farese,et al. Transgenic mice expressing high plasma concentrations of human apolipoprotein B100 and lipoprotein(a). , 1993, The Journal of clinical investigation.
[36] A. von Eckardstein,et al. Cell-derived unesterified cholesterol cycles between different HDLs and LDL for its effective esterification in plasma. , 1993, Arteriosclerosis and thrombosis : a journal of vascular biology.
[37] M. Jauhiainen,et al. Human plasma phospholipid transfer protein causes high density lipoprotein conversion. , 1993, The Journal of biological chemistry.
[38] C. Fielding,et al. Early incorporation of cell-derived cholesterol into pre-beta-migrating high-density lipoprotein. , 1988, Biochemistry.
[39] M. Jauhiainen,et al. Human plasma lecithin-cholesterol acyltransferase. An elucidation of the catalytic mechanism. , 1986, The Journal of biological chemistry.
[40] S. Edge,et al. Metabolism of low-density lipoproteins by cultured hepatocytes from normal and homozygous familial hypercholesterolemic subjects. , 1986, Biochimica et biophysica acta.
[41] S. Eisenberg,et al. High density lipoprotein metabolism. , 1984, Journal of lipid research.
[42] M. Phillips,et al. Kinetics and mechanism of free cholesterol exchange between human serum high- and low-density lipoproteins. , 1982, Biochemistry.
[43] D. B. Zilversmit,et al. A plasma inhibitor of triglyceride and cholesteryl ester transfer activities. , 1981, The Journal of biological chemistry.
[44] M. Brown,et al. Regulation of plasma cholesterol by lipoprotein receptors. , 1981, Science.
[45] M. Brown,et al. Saturation and suppression of hepatic lipoprotein receptors: a mechanism for the hypercholesterolemia of cholesterol-fed rabbits. , 1981, Proceedings of the National Academy of Sciences of the United States of America.
[46] D. H. Gregory,et al. Preferential utilization of free cholesterol from high-density lipoproteins for biliary cholesterol secretion in man. , 1978, Science.
[47] A. Gotto,et al. Revisiting Reverse Cholesterol Transport in the Context of High-Density Lipoprotein Free Cholesterol Bioavailability. , 2019, Methodist DeBakey cardiovascular journal.
[48] A. Gotto,et al. Cholesterol: Can't Live With It, Can't Live Without It. , 2019, Methodist DeBakey cardiovascular journal.
[49] F. Blanco-Vaca,et al. Quantification of In Vitro Macrophage Cholesterol Efflux and In Vivo Macrophage-Specific Reverse Cholesterol Transport. , 2015, Methods in molecular biology.